Cox AL - Search Results

1

An investigation of auto-reactivity after head injury.

Cox AL, Coles AJ, Nortje J, Bradley PG, Chatfield DA, Thompson SJ, Menon DK. Cox AL, et al. J Neuroimmunol. 2006 May;174(1-2):180-6. doi: 10.1016/j.jneuroim.2006.01.007. Epub 2006 Mar 6. J Neuroimmunol. 2006. PMID: 16519951

2

Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.

Brown JW, Martin PJ, Thorpe JW, Michell AW, Coles AJ, Cox AL, Vincent A, Zandi MS. Brown JW, et al. Among authors: cox al. J Neuroimmunol. 2014 Jun 15;271(1-2):66-8. doi: 10.1016/j.jneuroim.2014.03.012. Epub 2014 Mar 21. J Neuroimmunol. 2014. PMID: 24703099

3

Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.

Coles AJ, Thompson S, Cox AL, Curran S, Gurnell EM, Chatterjee VK. Coles AJ, et al. Among authors: cox al. Eur J Immunol. 2005 Dec;35(12):3694-703. doi: 10.1002/eji.200526128. Eur J Immunol. 2005. PMID: 16252254 Free article.

4

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).

Jones JL, Phuah CL, Cox AL, Thompson SA, Ban M, Shawcross J, Walton A, Sawcer SJ, Compston A, Coles AJ. Jones JL, et al. Among authors: cox al. J Clin Invest. 2009 Jul;119(7):2052-61. doi: 10.1172/JCI37878. Epub 2009 Jun 22. J Clin Invest. 2009. PMID: 19546505 Free PMC article.

5

B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis.

Thompson SA, Jones JL, Cox AL, Compston DA, Coles AJ. Thompson SA, et al. Among authors: cox al. J Clin Immunol. 2010 Jan;30(1):99-105. doi: 10.1007/s10875-009-9327-3. Epub 2009 Sep 10. J Clin Immunol. 2010. PMID: 19763798

6

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA. Coles AJ, et al. J Neurol. 2006 Jan;253(1):98-108. doi: 10.1007/s00415-005-0934-5. Epub 2005 Jul 27. J Neurol. 2006. PMID: 16044212

7

Recurrent myelitis and optic neuritis in a 29-year-old woman.

Cox A, Coles A, Antoun N, Malik O, Lucchinnetti C, Compston A. Cox A, et al. Lancet Neurol. 2005 Aug;4(8):510-6. doi: 10.1016/S1474-4422(05)70143-5. Lancet Neurol. 2005. PMID: 16033693 No abstract available.

8

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.

Cox AL, Thompson SA, Jones JL, Robertson VH, Hale G, Waldmann H, Compston DA, Coles AJ. Cox AL, et al. Eur J Immunol. 2005 Nov;35(11):3332-42. doi: 10.1002/eji.200535075. Eur J Immunol. 2005. PMID: 16231285 Free article. Clinical Trial.

9

Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series.

Zandi MS, Deakin JB, Morris K, Buckley C, Jacobson L, Scoriels L, Cox AL, Coles AJ, Jones PB, Vincent A, Lennox BR. Zandi MS, et al. Among authors: cox al. Schizophr Res. 2014 Dec;160(1-3):193-5. doi: 10.1016/j.schres.2014.11.001. Epub 2014 Nov 15. Schizophr Res. 2014. PMID: 25468187 No abstract available.

10

Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.

Keddie S, Crisp SJ, Blackaby J, Cox A, Coles A, Hart M, Church AJ, Vincent A, Zandi M, Lunn MP. Keddie S, et al. Eur J Neurol. 2018 Nov;25(11):1384-1388. doi: 10.1111/ene.13759. Epub 2018 Aug 31. Eur J Neurol. 2018. PMID: 30035842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters